Assembly Biosciences (NASDAQ: ASMB)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Other companies in Assembly Biosciences’s space includes: Alzamend Neuro (NASDAQ:ALZN), CytomX Therapeutics (NASDAQ:CTMX), Curis (NASDAQ:CRIS), Infinity Pharmaceuticals (NASDAQ:INFI) and Cue Biopharma (NASDAQ:CUE).
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting ASMB to rise to within 12 months (a possible 87.79% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $2.13 last updated August 12, 2022, 8:00 PM UTC.
The next Assembly Biosciences (ASMB) dividend date is projected to be Thursday, September 1, 2022.
Assembly Biosciences’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Assembly Biosciences.
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.